Form 13-F position report

EVOLENT HEALTH INC

Reported by LOOMIS SAYLES & CO L P

EVH 2 12/01/21 CUSIP 30050BAB7 Manager CIK 0000312348

Reported 0 shares, down 313,726 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2020
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 12 Through Q3 2020

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for EVOLENT HEALTH INC held by LOOMIS SAYLES & CO L P.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

20 managers reported EVOLENT HEALTH INC for Q3 2020.

Managers reporting EVOLENT HEALTH INC in Q3 2020.
Manager Activity Shares Change % of reported 13F Reported value Tenure
OAKTREE CAPITAL MANAGEMENT LP Added 8,126,000 +3,979,000 0.17% $8,039,000 2 qtrs
Russell Investments Group Ltd Added 2,155,000 +1,099,000 < 0.01% $2,110,000 2 qtrs
WOLVERINE ASSET MANAGEMENT LLC Unchanged 0 0 0.02% $2,011,000 4 qtrs
Linden Advisors LP Unchanged 500,000 0 < 0.01% $489,000 8 qtrs
BLAIR WILLIAM & CO IL Unchanged 127,000 0 < 0.01% $124,000 6 qtrs
EXCALIBUR MANAGEMENT CORP Reduced 70,000 -20,000 0.04% $69,000 3 qtrs
MORGAN STANLEY Unchanged 10,000 0 < 0.01% $10,000 4 qtrs
Citigroup Inc Unchanged 10,000 0 < 0.01% $10,000 7 qtrs
WELLS FARGO & COMPANY MN Unchanged 4,000 0 < 0.01% $4,000 11 qtrs
Birch Grove Capital LP Reduced 0 -23,825,000 0 $0 7 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2020
Filed
November 12, 2020
Filing type
13F-HR
Position type
CV BND

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.